Viewing nowCombinationExvalset Tablets 5/160mg
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Biotech Co., Ltd.

MFDS item code 201907958 · Approved 2019.11.18 · Insurance code 057600370
Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy
This medication is used to control blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy using amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients 65 years of age and older: Use caution when increasing the dose.
Use of this medicine is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn when administered during the second and third trimester of pregnancy; therefore, it should be immediately discontinued upon confirmation of pregnancy. There are patients who should not take this medication. For example, individuals allergic to this medication or other similar medications, pregnant or potentially pregnant women, nursing mothers, and patients with severe renal or liver dysfunction should not take this medication. Additionally, for diabetic patients with moderate to severe renal dysfunction, concomitant use of this medication with certain other drugs may be risky and should be avoided. This medication can cause hypotension in patients with decreased sodium or fluid levels, making it important to verify and supplement this condition before administration. Patients with high potassium levels should also exercise caution, and frequent monitoring of blood potassium levels is required when taken with potassium supplements or potassium-rich medications. Patients with renal vascular issues or those who have had kidney transplants may also be affected in renal function upon administering this medication, requiring careful monitoring. Severe allergic reactions known as angioedema may occur, so if symptoms such as swelling of the face, lips, or tongue appear, the medication should be discontinued immediately. Patients with heart failure or following a myocardial infarction should closely monitor renal function while taking this medication, as hypotension or renal failure may occur in some cases. Caution is advised when driving or operating machinery as dizziness or fatigue may occur. This medication can interact with various other medications, so patients should inform healthcare providers of any other medications they are taking. In cases of overdose, severe hypotension or heart problems may occur, requiring immediate emergency intervention. The safety and effectiveness of this medication in patients under 18 years old have not been established, so it is not recommended for use in this population. For elderly patients, the usual adult dose can be administered, but careful monitoring is required. Regular liver function or renal function tests are recommended during treatment with this medication.
Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, position-related dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pain in the pharynx and larynx, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle cramping, lethargy, frequent urination, polyuria, erectile dysfunction, edema, limbal edema, facial swelling, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney injury, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infections, viral infections, diplopia, thrombocytopenia, leukopenia, allergy reactions, hyperglycemia, insomnia, mood changes, tremors, sensory loss, dysgeusia, peripheral neuropathy, hypertonic muscle syndromes, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival dysplasia, gastritis, neuroexcitation, sensory loss, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius. Proper storage will safely preserve the medication's effectiveness.
Dark yellow oval film-coated tablets
30 tablets/box [10 tablets/PTP X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
Daewon Biotech Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.